A groundbreaking study reveals that scientists have discovered a method to reprogram the pancreas to produce GLP-1s naturally, eliminating the need for Ozempic and offering new hope for sustainable weight loss.
Two biotech companies are developing groundbreaking gene therapies that could lead to a single injection for weight loss and blood sugar control. Initial tests show promising results in mice, with human trials on the horizon.